Unconventional myosins and the regulation of gut barrier integrity and restitution during inflammation
非常规肌球蛋白以及炎症期间肠道屏障完整性和恢复的调节
基本信息
- 批准号:10443882
- 负责人:
- 金额:$ 45.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-15 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalActomyosinAcuteAddressAdherens JunctionAdhesionsAffectAirApicalBasal CellBindingBiochemicalBiological MarkersBiosensorCRISPR/Cas technologyCeliac DiseaseCell Culture TechniquesCell DeathCell Differentiation processCell LineCell PolarityCell membraneCellsChronic PhaseColitisComplexCrohn&aposs diseaseCytoskeletonDataDefectDefense MechanismsDestinationsDetergentsDevelopmentDigestive System DisordersDiseaseDisease remissionDown-RegulationEpithelialEpithelial AttachmentEpithelial CellsEventExtracellular MatrixFluorescence Resonance Energy TransferFractionationGastrointestinal DiseasesGenesGeneticGut MucosaHealthHumanImageImmunoprecipitationImpairmentIn VitroIncidenceInfectious colitisInflammationInflammatoryInflammatory Bowel DiseasesInjuryIntestinal DiseasesIntestinal MucosaIntestinal permeabilityKnock-outKnockout MiceKnowledgeLeaky GutLinkLiquid substanceMalignant NeoplasmsMeasurementMediatingMicrofilamentsMicroscopyModelingMolecularMorbidity - disease rateMorphogenesisMotorMucositisMucous MembraneMuscleMyosin ATPaseMyosin Type IINeuronsOrganoidsOutcomePathogenesisPatientsPeriodicityPermeabilityPharmacologyPhysiologyPreventionProcessPublic HealthRecoveryRegulationResolutionRoleScaffolding ProteinSignal TransductionStructureTestingTherapeutic InterventionTight JunctionsUlcerative ColitisWestern Blottingattenuationcell motilitycohortcytokinedisorder controlepithelial injuryexperimental studygut homeostasisgut inflammationhealingimprovedin vivoinjuredinnovationinsightintestinal barrierintestinal epitheliumknockout animalmonolayermortalitymotor controlmouse modelmutantnew therapeutic targetnon-muscle myosinnoveloverexpressionpathogenic bacteriapreventrepairedrestorationtargeted treatmenttumor growthwoundwound healing
项目摘要
PROJECT SUMMARY: Disruption of the intestinal epithelial barrier in patients with inflammatory bowel
diseases (IBD) involves disassembly of epithelial tight junctions (TJ) and adherens junctions (AJ), along with
formation of mucosal wounds due to excessive epithelial cell death. Restoration of the gut barrier (epithelial
restitution) is critical for achieving remission of the disease and it involves mucosal wound healing and AJ/TJ
reassembly. Both processes are mediated by common molecular events, most notably, dramatic remodeling of
the epithelial actomyosin cytoskeleton. An unconventional myosin 18A (Myo18A) is a unique PDZ-domain
containing scaffolding protein that acts as an essential regulator of actin filaments and their motor, non-muscle
myosin II (NM II). Myo18A is known to control neuronal and muscle morphogenesis, as well as tumor growth
and dissemination, however its functions in the gut have not been previously investigated. Our preliminary data
suggests that Myo18A is abundantly expressed in normal human intestinal epithelium and it is a novel
component of epithelial junctions, Furthermore, Myo18A depletion leads to various functional defects, including
disruption of the epithelial barrier, attenuation of wound healing and impairment of 3-D epithelial
morphogenesis. Importantly, we observed a marked downregulation of Myo18A expression in the intestinal
epithelium of ulcerative colitis patients. This exciting preliminary data provides a strong scientific premise for
the following innovative hypothesis: Myo18A is a novel regulator of the intestinal epithelial barrier
integrity and restitution, and its depletion promotes gut leakiness and inhibits mucosal healing in IBD
patients.
This hypothesis will be tested in the following Aims: (1) to determine the roles of Myo18A in the regulation of
intestinal epithelial cell migration and ECM adhesion; (2) to delineate the mechanisms of Myo18A-dependent
assembly of the epithelial barrier and establishment of the apico-basal cell polarity; 3) to examine the roles of
Myo18A in regulating disruption and restitution of the intestinal epithelial barrier in vivo. The Aims will be
accomplished by studies utilizing in vitro intestinal epithelial cell monolayers, ex vivo colonic organoids
generated from IBD mucosa and in vivo murine models of epithelial injury and restitution. Roles of Myo18A will
be examined by a combination of functional (permeability measurements, wound healing), biochemical
(immunoblotting, detergent fractionation), imaging (FRET biosensors, super-resolution microscopy), and
genetic (CRISPR/Cas9 gene editing, overexpression of deletion mutants, knockout mice) approaches.
Significance: the proposed study will yield novel insights into the mechanisms that regulate intestinal epithelial
injury and restitution during inflammation. It will also identify new therapeutic targets to prevent breakdown and
enhance reparation of the gut barrier in patients with digestive diseases.
项目摘要:炎症性肠患者肠上皮屏障的破坏
疾病(IBD)涉及上皮紧密连接(TJ)和粘附连接(AJ)的分解,以及
由于上皮细胞过度死亡而形成粘膜伤口。恢复肠道屏障(上皮细胞
恢复)对于实现疾病缓解至关重要,它涉及粘膜伤口愈合和 AJ/TJ
重新组装。这两个过程都是由常见的分子事件介导的,最值得注意的是,
上皮肌动球蛋白细胞骨架。非常规肌球蛋白 18A (Myo18A) 是一个独特的 PDZ 结构域
含有支架蛋白,可作为肌动蛋白丝及其运动、非肌肉的重要调节剂
肌球蛋白 II (NM II)。 Myo18A 已知可控制神经元和肌肉形态发生以及肿瘤生长
和传播,然而其在肠道中的功能以前尚未被研究过。我们的初步数据
表明Myo18A在正常人肠上皮中大量表达,并且是一种新的
此外,Myo18A 耗竭会导致各种功能缺陷,包括
上皮屏障破坏、伤口愈合减弱和 3-D 上皮损伤
形态发生。重要的是,我们观察到肠道中 Myo18A 表达显着下调
溃疡性结肠炎患者的上皮。这一令人兴奋的初步数据为
以下创新假设:Myo18A 是肠上皮屏障的新型调节剂
完整性和恢复性,其消耗会促进 IBD 肠道渗漏并抑制粘膜愈合
患者。
该假设将在以下目的中得到检验:(1)确定Myo18A在调节中的作用
肠上皮细胞迁移和ECM粘附; (2) 描绘Myo18A依赖性机制
上皮屏障的组装和顶端基底细胞极性的建立; 3)检查角色
Myo18A 调节体内肠上皮屏障的破坏和恢复。目标将是
通过利用体外肠上皮细胞单层、离体结肠类器官的研究完成
由 IBD 粘膜和上皮损伤和恢复的体内小鼠模型产生。 Myo18A 的角色将
通过功能(渗透性测量、伤口愈合)、生化的组合进行检查
(免疫印迹、洗涤剂分级分离)、成像(FRET 生物传感器、超分辨率显微镜)和
遗传(CRISPR/Cas9 基因编辑、缺失突变体的过度表达、基因敲除小鼠)方法。
意义:拟议的研究将为调节肠上皮细胞的机制提供新的见解
炎症期间的损伤和恢复。它还将确定新的治疗靶点,以防止崩溃和
增强消化系统疾病患者肠道屏障的修复。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Regulation of Epithelial and Endothelial Barriers by Molecular Chaperones.
分子伴侣对上皮和内皮屏障的调节。
- DOI:
- 发表时间:2024-02-21
- 期刊:
- 影响因子:6
- 作者:Lechuga, Susana;Marino;Naydenov, Nayden G;Zafar, Atif;Braga;Ivanov, Andrei I
- 通讯作者:Ivanov, Andrei I
Unique and redundant functions of cytoplasmic actins and nonmuscle myosin II isoforms at epithelial junctions.
上皮连接处细胞质肌动蛋白和非肌肉肌球蛋白 II 亚型的独特和冗余功能。
- DOI:
- 发表时间:2022-09
- 期刊:
- 影响因子:5.2
- 作者:Ivanov, Andrei I;Lechuga, Susana;Marino;Naydenov, Nayden G
- 通讯作者:Naydenov, Nayden G
Inflammation modulates intercellular adhesion and mechanotransduction in human epidermis via ROCK2.
炎症通过 ROCK2 调节人表皮细胞间粘附和机械转导。
- DOI:
- 发表时间:2023-03-17
- 期刊:
- 影响因子:5.8
- 作者:Shutova, Maria S;Borowczyk, Julia;Russo, Barbara;Sellami, Sihem;Drukala, Justyna;Wolnicki, Michal;Brembilla, Nicolo C;Kaya, Gurkan;Ivanov, Andrei I;Boehncke, Wolf
- 通讯作者:Boehncke, Wolf
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrei Ivanovich Ivanov其他文献
Andrei Ivanovich Ivanov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrei Ivanovich Ivanov', 18)}}的其他基金
Novel cytoskeletal mechanisms of pathogenic bacteria interactions with intestinal epithelium
病原菌与肠上皮相互作用的新细胞骨架机制
- 批准号:
10663379 - 财政年份:2022
- 资助金额:
$ 45.26万 - 项目类别:
Novel cytoskeletal mechanisms of pathogenic bacteria interactions with intestinal epithelium
病原菌与肠上皮相互作用的新细胞骨架机制
- 批准号:
10663379 - 财政年份:2022
- 资助金额:
$ 45.26万 - 项目类别:
Novel cytoskeletal mechanisms of pathogenic bacteria interactions with intestinal epithelium
病原菌与肠上皮相互作用的新细胞骨架机制
- 批准号:
10516636 - 财政年份:2022
- 资助金额:
$ 45.26万 - 项目类别:
Unconventional myosins and the regulation of gut barrier integrity and restitution during inflammation
非常规肌球蛋白以及炎症期间肠道屏障完整性和恢复的调节
- 批准号:
10261489 - 财政年份:2020
- 资助金额:
$ 45.26万 - 项目类别:
Unconventional myosins and the regulation of gut barrier integrity and restitution during inflammation
非常规肌球蛋白以及炎症期间肠道屏障完整性和恢复的调节
- 批准号:
10094455 - 财政年份:2020
- 资助金额:
$ 45.26万 - 项目类别:
Actomyosin cytoskeleton and the regulation of intestinal eipithelial barrier
肌动球蛋白细胞骨架与肠上皮屏障的调节
- 批准号:
9304208 - 财政年份:2016
- 资助金额:
$ 45.26万 - 项目类别:
Actomyosin cytoskeleton and the regulation of intestinal eipithelial barrier
肌动球蛋白细胞骨架与肠上皮屏障的调节
- 批准号:
9606158 - 财政年份:2016
- 资助金额:
$ 45.26万 - 项目类别:
Junctional exocytosis and breakdown of the intestinal barrier in inflammation
炎症中的连接胞吐作用和肠道屏障的破坏
- 批准号:
8243607 - 财政年份:2010
- 资助金额:
$ 45.26万 - 项目类别:
Actin dynamics and regulation of epithelial barrier in intestinal inflammation
肠道炎症中肌动蛋白动力学和上皮屏障的调节
- 批准号:
7980853 - 财政年份:2010
- 资助金额:
$ 45.26万 - 项目类别:
相似国自然基金
由actomyosin介导的集体性细胞迁移对唇腭裂发生的影响的研究
- 批准号:82360313
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
鱼糜肌动球蛋白的增效转化及其氧化控制分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:59 万元
- 项目类别:面上项目
基于Pickering纳米乳液脂质诱导肌动球蛋白凝胶的空间位阻效应及其机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
低频超声场下肉品肌动球蛋白敏感结构域及其构象变化的作用机制
- 批准号:31901612
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
基于飞秒激光微纳手术研究亚细胞尺度分子马达网络调控细胞三维运动的生物物理机理
- 批准号:31701215
- 批准年份:2017
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Rac1 and the actin cytoskeleton in renal tubular repair
Rac1 和肌动蛋白细胞骨架在肾小管修复中的作用
- 批准号:
10739610 - 财政年份:2023
- 资助金额:
$ 45.26万 - 项目类别:
The role of myosin II in tendon repair under glucose control
肌球蛋白 II 在葡萄糖控制下肌腱修复中的作用
- 批准号:
10649584 - 财政年份:2022
- 资助金额:
$ 45.26万 - 项目类别:
The role of myosin II in tendon repair under glucose control
肌球蛋白 II 在葡萄糖控制下肌腱修复中的作用
- 批准号:
10440751 - 财政年份:2022
- 资助金额:
$ 45.26万 - 项目类别:
Role of AJC in umbrella cell function and dysfunction
AJC 在伞细胞功能和功能障碍中的作用
- 批准号:
10482413 - 财政年份:2021
- 资助金额:
$ 45.26万 - 项目类别:
Viscotaxis: Novel cell migration mechanisms regulated by microenvironmental viscosity
Viscotaxis:微环境粘度调节的新型细胞迁移机制
- 批准号:
10622450 - 财政年份:2021
- 资助金额:
$ 45.26万 - 项目类别: